Contract facts
FederalNo full NAICS 493110 intel page yet. Browse NAICS intelligence
PHARMACEUTICAL REVERSE DISTRIBUTION is a federal award for 248-Network Contract Office 8 (36C248) held by Returns 'R' Us, Inc. Estimated value $549K ($-93,452.63 obligated). Current period of performance ends Feb 28, 2021. Place of performance: GAINESVILLE FL.
Recompete timing
PublicCurrent PoP ended Feb 28, 2021 (2000 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24819F0160?
36C24819F0160 (Pharmaceutical reverse distribution) is a 248-Network Contract Office 8 (36C248) award with a potential value of $549K, currently held by Returns 'R' Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C248-19-F-0160?
36C248-19-F-0160 is the dashed form of PIID 36C24819F0160 (Pharmaceutical reverse distribution), held by Returns 'R' Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24819F0160?
248-Network Contract Office 8 (36C248) awarded 36C24819F0160 to Returns 'R' Us, Inc (potential $549K).
Who is the incumbent on 36C24819F0160?
Returns 'R' Us, Inc is the incumbent. The current period of performance ends Feb 28, 2021.
When does Returns 'R' Us, Inc’s 36C24819F0160 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.